COMPANY PRESENTATION

 Search News:
 

 
 
 

Altech Batteries Pioneering Sustainable Energy Solutions
05 Mar 2025 - Innovative Sodium Chloride Batteries for Grid Storage

Sequoia Financial Group (ASX:SEQ) 1H FY25 results presentation, February 2025
29 Nov 2024 - Sequoia Financial Group (ASX:SEQ) Managing Director and CEO Garry Crole and CFO Lizzie Tan present on the group's first-half FY25 financial results.

IVE Group (ASX:IGL) 1HFY25 results presentation
25 Feb 2025 - Higher margins, cost synergies and strong cash flow drive upgraded profit outlook

Immutep’s therapies move towards late-stage development
19 Feb 2025 - Encouraging trial results support next steps for lead candidate eftilagimod alpha

Alterity Therapeutics advances ATH434 for Multiple System Atrophy
19 Feb 2025 - Phase 2 trial shows promising results in slowing disease progression

Nico Resources advances Wingellina Nickel-Cobalt Project
19 Feb 2025 - Feasibility studies progress as demand for battery metals rises

Australian Foundation Investment Company (ASX:AFI) Half Year Results, January 2025
24 Jan 2025 - CEO and Managing Director Mark Freeman and Portfolio Manager David Grace discuss AFIC's half-year results.

Alterity Therapeutics (ASX:ATH) - Webinar Presentation
29 Nov 2024 - Dr David Stamler - CEO - Alterity Therapeutics Limited (ASX:ATH) is developing first-in-class therapies to treat neurodegenerative disease. The company's lead drug candidate, ATH434, has demonstrated efficacy in several animal models of Parkinsonian disorders and is being evaluated in clinical trials.

TMK Energy (ASX:TMK) - Webinar Presentation
29 Nov 2024 - Dougal Ferguson - CEO - TMK Energy Limited’s (ASX:TMK) flagship project, the Gurvantes XXXV Project, is a comprehensive Coal Seam Gas exploration initiative covering an expansive area of approximately 8,400 km2 in the South Gobi basin of Mongolia.

INOVIQ (ASX:IIQ) - Webinar Presentation
13 Dec 2024 - Dr Leearne Hinch - CEO - INOVIQ Limited (ASX:IIQ) is developing and commercialising a portfolio of diagnostic and exosome-based products for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases.